Cefaclor
سفاکلر
🦠 Antiinfectives For Systemic UseSecond-generation cephalosporin
Market / country: 🇺🇸 USA
Ceclor (US)
🧮 Dose calculator
Respiratory tract infection · Regimen source: FDA Cefaclor caps. · Dosage and Administration
- • More severe infections or less susceptible organisms: dose may be doubled. FDA Cefaclor caps. · Dosage and Administration
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Allergy to cephalosporins. FDA Cefaclor caps. · Contraindications
Formulations
- 250 mg capsule — capsule 🇺🇸 USA FDA Cefaclor caps. · How Supplied
- 500 mg capsule — capsule 🇺🇸 USA FDA Cefaclor caps. · How Supplied
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Cefaclor caps. · Pregnancy ─ Teratogenic Effects ─ Pregnancy Category B
“Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Cefaclor caps. · Nursing Mothers
“Caution should be exercised when cefaclor is administered to a nursing woman.”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Cefaclor caps. · Pediatric Use
“Safety and effectiveness of this product for use in infants less than 1 month of age have not been established.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Cefaclor caps. · Geriatric Use
“Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful in monitor renal function (see DOSAGE AND ADMINISTRATION ).”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA065146
- DailyMed (FDA label)FDA Cefaclor caps.
- MedlinePlus (NIH)Cefaclor
- WHO ATC/DDDJ01DC04
- Darooyab (Iran)Cefaclor
🇮🇷 Registered in Iran Darooyab · G-309/Cefaclor
Dosage forms with Iranian generic codes, per Darooyab.
- 06036 · CEFACLOR 125MG/5ML 100ML SYRUP · شربت سفاکلر ۱۲۵ میلیگرم / ۵ میلیلیتر ۱۰۰ میلیلیتر
- 12100 · CEFACLOR 125MG/60ML SYR · سفاکلر ۱۲۵ میلیگرم / ۶۰ میلیلیتر
- 16824 · CEFACLOR 250MG TAB · قرص سفاکلر ۲۵۰ میلیگرم
- 12639 · CEFACLOR 250MG/5ML 100ML SUSP · سوسپانسیون سفاکلر ۲۵۰ میلیگرم / ۵ میلیلیتر ۱۰۰ میلیلیتر
- 06037 · CEFACLOR 250MG/5ML 100ML SYRUP · شربت سفاکلر ۲۵۰ میلیگرم / ۵ میلیلیتر ۱۰۰ میلیلیتر
- 12101 · CEFACLOR 250MG/60ML SYR · سفاکلر ۲۵۰ میلیگرم / ۶۰ میلیلیتر
- 19333 · CEFACLOR 500MG CAP · کپسول سفاکلر ۵۰۰ میلیگرم
- 14487 · CEFACLOR 500MG TAB · قرص سفاکلر ۵۰۰ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Cefaclor caps. · How SuppliedFDA Cefaclor caps. · Dosage and AdministrationFDA Cefaclor caps. · ContraindicationsFDA Cefaclor caps. · Pregnancy ─ Teratogenic Effects ─ Pregnancy Category BFDA Cefaclor caps. · Nursing MothersFDA Cefaclor caps. · Pediatric UseFDA Cefaclor caps. · Geriatric UseFDA Cefaclor caps. · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-309/Cefaclor
- Clinical review⚠ Unverified